Pharmaceutical companies are working on ways to evade copay accumulator
In an effort to coax patients away from expensive drugs, pharmacy benefits managers (PBMs) have introduced a new “copay accumulator”
Read More
Part D/Prescription Drugs
What A U.S.-China Trade War Could Mean For The Opioid Epidemic
(By Matthew Garcia for Kaiser Health News) The American struggle to curb opioid addiction could become collateral damage in President
Read MoreAs drug resistance grows, combining antibiotics could turn up new treatments
(By Megan Thielking for STAT) Combining certain antibiotics could help them pack a one-two punch against harmful bacteria, according to a new study
Read MoreMedicare’s money traps
Medicare isn’t free and it may end up costing more than you expect. In fact, the entire Medicare spectrum of
Read MorePfizer hikes price of 100 drugs
(By Alia Paavola for Becker’s Hospital Review) Pfizer, the largest pharmaceutical company in the U.S., increased the price of 100
Read MoreAcceleron blood disease drug hits goal in pivotal clinical trial
(By Adam Feurerstein for STAT) Acceleron Pharma said Thursday that its experimental drug luspatercept significantly reduced the need for blood
Read More340B hospitals, contract pharmacies need more
The Government Accountability Office (GAO) said that HHS’ Health Resources and Services Administration (HRSA) should take new steps to ensure
Read More5 latest FDA approvals
(By Mackenzie Bean for Becker’s Hospital Review) Here are the five latest drugs or medical devices approved by the FDA
Read MoreAmazon to buy online pharmacy PillPack for about $1B: 5 things to know
(By Morgan Haefner for Becker’s Hospital Review) Amazon entered into a definitive merger agreement June 28 to acquire online pharmacy PillPack for
Read MoreOpioid Makers Cut Back On Marketing Payments To Doctors
(By Charles Ornstein and Ryann Grochowski Jones from NPR and ProPublica) The past two years have been a time of
Read More